Serial skin photographs predict significant breast radiation dermatitis by treatment week three
A dual-view AI model predicted grade ≥2 breast radiation dermatitis with AUC 0.91 overall and approximately 0.80 by week three.
A dual-view AI model predicted grade ≥2 breast radiation dermatitis with AUC 0.91 overall and approximately 0.80 by week three.
In 40 breast and chest wall plans, DynamicArc improved coverage and robustness in challenging anatomies but increased thyroid dose and hotspots.
GEC-ESTRO supports interstitial brachytherapy boost for selected high-risk breast cancer patients, emphasizing dose escalation with reduced surrounding tissue exposure.
After 16.5 years, left atrial maximum dose was associated with major cardiac events, while left ventricular mean dose tracked with coronary disease.
Adding SBRT or surgery to first-line systemic therapy did not improve progression-free or overall survival in oligometastatic breast cancer.
In 2,057 women, hypofractionated breast RT showed less acute pain and skin toxicity, while severe late effects remained uncommon.
Concurrent, deferred, or earlier cranial RT produced no significant survival difference in patients receiving pyrotinib for HER2-positive breast brain metastases.
Reducing breast CBCT acquisition from 200° to 120° maintained submillimeter average registration differences while reducing central imaging dose by 33%.
Re-irradiation plus regional or capacitive hyperthermia achieved 94% complete response across 17 breast cancer recurrences with no grade ≥3 toxicity.
Pre-treatment physicist consultation was associated with higher EPID gamma passing rates and smaller setup shifts during breast radiotherapy.
Permanent palladium-103 breast seed implantation achieved 100% 10-year local control with no grade ≥3 toxicity in selected early breast cancer.
Semi-automated FDG PET/CT produced more reproducible nodal target volumes than manual MRI and identified all metastatic nodes consistently.
Across 3,817 patients, severe toxicity was uncommon with RT plus ADCs, except for a radiation-necrosis signal with intracranial RT and T-DM1.
Skin V40 >90 cc nearly quadrupled breast lymphedema odds, while mammographic skin thickening provided an objective detection signal.
A simple counting task added about 19 seconds to prolonged DIBH in breast cancer patients after oxygenation and hyperventilation.